- 积分
- 340
- 威望
- 340
- 包包
- 777
|
Mesenchymal stem cells combat sepsis1 l6 M6 [. {* o7 C- n7 B
( d4 Q% X! z& _, m
Alan Tyndall1 & Vito Pistoia2) S3 u: l6 D1 w2 Z! _ o- U, h1 S4 B
- x! `7 G) D/ D8 q5 P2 K: f
Alan Tyndall is in the Department of Rheumatology, Felix Platter Spital, Burgfelderstrasse 101, 4012 Basel, Switzerland
% {# N! Z; e2 P0 |+ l8 F1 l8 c, W/ R! Ge-mail: alan.tyndall@fps-basel.ch
; ~+ A6 z* S/ S- LVito Pistoia is in the Laboratory of Oncology, Department of Experimental and Laboratory Medicine, Largo G. Gaslini 5, 16147 Genoa, Italy.
4 x& ~: {% Y8 TAbstract, z2 p! u0 k7 @0 m/ { s
A new approach to the treatment of sepsis relies on the infusion of mesenchymal stem cells, multipotent cells used experimentally to treat a range of medical conditions. In mouse models, the cells seem to reprogram immune cells that can contribute to sepsis
; A }6 d! g! ]; _8 ` Q. ?链接地址:http://www.nature.com/nm/journal/v15/n1/full/nm0109-18.html |
|